More than a third of eligible beneficiaries on PrEP for HIV, but disparities persist
New preliminary data from the Centers for Disease Control and Prevention (CDC) indicates more than a third of people who could benefit from preexposure prophylaxis (PrEP) for HIV received a prescription for it in 2022. Expanding PrEP use is a key part of the CDC’s Ending the HIV Epidemic in the U.S. (EHE) initiative, which…